LifeFlight study to include Cannon Co.

Cannon County is being included in a national trial being conducted by Vanderbilt University Medical Center to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by administering plasma to these patients while in flight to the hospital.

Randomized patients who are at risk of hemorrhaging could receive two units of plasma, which can improve a patient's ability to clot and ultimately survive their injuries

The study is currently underway via LifeFlight's Clarksville base and will soon be expanded to include some patients being flown to Vanderbilt University Hospital from the area covered by LifeFlight's new Rutherford County base.

Uncontrolled bleeding is one of the most serious threats to the severely injured patient, often resulting in early death or the development of comp-lications such as multiple organ failure

Funded by the U.S. Department of Defense, the Prehospital Air Medical Plasma (PAMPer) trial will assess whether a pre-hospital infusion of plasma can improve mortality and reduce the total amount of blood transfusions needed as compared to standard air medical care.

Cannon County is being included in a national trial being conducted by Vanderbilt University Medical Center to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by admini-stering plasma to these patients while in flight to the hospital.

Randomized patients who are at risk of hemorrhaging could receive two units of plasma, which can improve a patient's ability to clot and ultimately survive their injuries.

The study is currently underway via LifeFlight's Clarksville base and will soon be expanded to include some patients being flown to Vanderbilt University Hospital from the area covered by LifeFlight's new Rutherford County base.